Cargando…

Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis

Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Emb...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bao-Zhu, Threapleton, Diane Erin, Wang, Ji-Yao, Xu, Jian-Ming, Yuan, Jin-Qiu, Zhang, Chao, Li, Peng, Ye, Qian-Ling, Guo, Biao, Mao, Chen, Ye, Dong-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541168/
https://www.ncbi.nlm.nih.gov/pubmed/26290044
http://dx.doi.org/10.1136/bmj.h4052
_version_ 1782386340823826432
author Li, Bao-Zhu
Threapleton, Diane Erin
Wang, Ji-Yao
Xu, Jian-Ming
Yuan, Jin-Qiu
Zhang, Chao
Li, Peng
Ye, Qian-Ling
Guo, Biao
Mao, Chen
Ye, Dong-Qing
author_facet Li, Bao-Zhu
Threapleton, Diane Erin
Wang, Ji-Yao
Xu, Jian-Ming
Yuan, Jin-Qiu
Zhang, Chao
Li, Peng
Ye, Qian-Ling
Guo, Biao
Mao, Chen
Ye, Dong-Qing
author_sort Li, Bao-Zhu
collection PubMed
description Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori.
format Online
Article
Text
id pubmed-4541168
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-45411682015-08-28 Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis Li, Bao-Zhu Threapleton, Diane Erin Wang, Ji-Yao Xu, Jian-Ming Yuan, Jin-Qiu Zhang, Chao Li, Peng Ye, Qian-Ling Guo, Biao Mao, Chen Ye, Dong-Qing BMJ Research Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori. BMJ Publishing Group Ltd. 2015-08-19 /pmc/articles/PMC4541168/ /pubmed/26290044 http://dx.doi.org/10.1136/bmj.h4052 Text en © Li et al 2015 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Li, Bao-Zhu
Threapleton, Diane Erin
Wang, Ji-Yao
Xu, Jian-Ming
Yuan, Jin-Qiu
Zhang, Chao
Li, Peng
Ye, Qian-Ling
Guo, Biao
Mao, Chen
Ye, Dong-Qing
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title_full Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title_fullStr Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title_full_unstemmed Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title_short Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
title_sort comparative effectiveness and tolerance of treatments for helicobacter pylori: systematic review and network meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541168/
https://www.ncbi.nlm.nih.gov/pubmed/26290044
http://dx.doi.org/10.1136/bmj.h4052
work_keys_str_mv AT libaozhu comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT threapletondianeerin comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT wangjiyao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT xujianming comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT yuanjinqiu comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT zhangchao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT lipeng comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT yeqianling comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT guobiao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT maochen comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis
AT yedongqing comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis